Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Complicacions infeccioses; Càncer
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Departament de Salut de la Generalitat de Catalunya (DS) |
| Repositorio: | Scientia. Dipòsit d'Informació Digital del Departament de Salut |
| OAI Identifier: | oai:scientiasalut.gencat.cat:11351/6888 |
| Acceso en línea: | https://hdl.handle.net/11351/6888 |
| Access Level: | acceso abierto |
| Palabra clave: | COVID-19 (Malaltia) Càncer - Complicacions Infeccions oportunistes DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections DISEASES::Neoplasms Other subheadings::Other subheadings::Other subheadings::/complications DISEASES::Virus Diseases::Coinfection ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus ENFERMEDADES::neoplasias Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones ENFERMEDADES::virosis::coinfección |
| id |
ES_97ff77c08f7a5d4e4077e38ced1135f5 |
|---|---|
| oai_identifier_str |
oai:scientiasalut.gencat.cat:11351/6888 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study |
| title |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study |
| spellingShingle |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study Gudiol, Carlota COVID-19 (Malaltia) Càncer - Complicacions Infeccions oportunistes DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections DISEASES::Neoplasms Other subheadings::Other subheadings::Other subheadings::/complications DISEASES::Virus Diseases::Coinfection ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus ENFERMEDADES::neoplasias Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones ENFERMEDADES::virosis::coinfección |
| title_short |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study |
| title_full |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study |
| title_fullStr |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study |
| title_full_unstemmed |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study |
| title_sort |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study |
| dc.creator.none.fl_str_mv |
Gudiol, Carlota Durà-Miralles, X. Aguilar-Company, Juan Hernández-Jiménez, P. Martínez-Cutillas, M. Fernández-Avilés, Francesc |
| author |
Gudiol, Carlota |
| author_facet |
Gudiol, Carlota Durà-Miralles, X. Aguilar-Company, Juan Hernández-Jiménez, P. Martínez-Cutillas, M. Fernández-Avilés, Francesc |
| author_role |
author |
| author2 |
Durà-Miralles, X. Aguilar-Company, Juan Hernández-Jiménez, P. Martínez-Cutillas, M. Fernández-Avilés, Francesc |
| author2_role |
author author author author author |
| dc.contributor.none.fl_str_mv |
Institut Català de la Salut [Gudiol C] Department of Infectious Diseases, Biostatistics Unit, Bellvitge University Hospital, Bellvitge Institute for Biomedical Research (IDIBELL), University of Barcelona, Barcelona, Spain. Institut Català d’Oncologia, IDIBELL, University of Barcelona, Barcelona, Spain. Spainsh Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Durà-Miralles X] Department of Infectious Diseases, Biostatistics Unit, Bellvitge University Hospital, Bellvitge Institute for Biomedical Research (IDIBELL), University of Barcelona, Barcelona, Spain. Spainsh Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Aguilar-Company J] Servei d’Oncologia Mèdica; Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Hernández-Jiménez P] Infectious Diseases Unit, 12 de Octubre University Hospital, Madrid, Spain. [Martínez-Cutillas M] Medical Oncology Department, Puerta de Hierro University Hospital, Madrid, Spain. [Fernandez-Avilés F] Bone Marrow Transplantation Unit, Department of Haematology, Hospital Clinic of Barcelona, Spain Vall d'Hebron Barcelona Hospital Campus |
| dc.subject.none.fl_str_mv |
COVID-19 (Malaltia) Càncer - Complicacions Infeccions oportunistes DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections DISEASES::Neoplasms Other subheadings::Other subheadings::Other subheadings::/complications DISEASES::Virus Diseases::Coinfection ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus ENFERMEDADES::neoplasias Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones ENFERMEDADES::virosis::coinfección |
| topic |
COVID-19 (Malaltia) Càncer - Complicacions Infeccions oportunistes DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections DISEASES::Neoplasms Other subheadings::Other subheadings::Other subheadings::/complications DISEASES::Virus Diseases::Coinfection ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus ENFERMEDADES::neoplasias Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones ENFERMEDADES::virosis::coinfección |
| description |
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Complicacions infeccioses; Càncer |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021 2022 2022 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/11351/6888 |
| url |
https://hdl.handle.net/11351/6888 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Journal of Infection;83(3) https://doi.org/10.1016/j.jinf.2021.07.014 |
| dc.rights.none.fl_str_mv |
Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
Scientia reponame:Scientia. Dipòsit d'Informació Digital del Departament de Salut instname:Departament de Salut de la Generalitat de Catalunya (DS) |
| instname_str |
Departament de Salut de la Generalitat de Catalunya (DS) |
| reponame_str |
Scientia. Dipòsit d'Informació Digital del Departament de Salut |
| collection |
Scientia. Dipòsit d'Informació Digital del Departament de Salut |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869414141243949056 |
| spelling |
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international studyGudiol, CarlotaDurà-Miralles, X.Aguilar-Company, JuanHernández-Jiménez, P.Martínez-Cutillas, M.Fernández-Avilés, FrancescCOVID-19 (Malaltia)Càncer - ComplicacionsInfeccions oportunistesDISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus InfectionsDISEASES::NeoplasmsOther subheadings::Other subheadings::Other subheadings::/complicationsDISEASES::Virus Diseases::CoinfectionENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por CoronavirusENFERMEDADES::neoplasiasOtros calificadores::Otros calificadores::Otros calificadores::/complicacionesENFERMEDADES::virosis::coinfecciónCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Complicacions infeccioses; CàncerCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Complicaciones infecciosas; CáncerCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Infectious complications; CancerBackground We aimed to describe the epidemiology, risk factors, and clinical outcomes of co-infections and superinfections in onco-hematological patients with COVID-19. Methods International, multicentre cohort study of cancer patients with COVID-19. All patients were included in the analysis of co-infections at diagnosis, while only patients admitted at least 48 h were included in the analysis of superinfections. Results 684 patients were included (384 with solid tumors and 300 with hematological malignancies). Co-infections and superinfections were documented in 7.8% (54/684) and 19.1% (113/590) of patients, respectively. Lower respiratory tract infections were the most frequent infectious complications, most often caused by Streptococcus pneumoniae and Pseudomonas aeruginosa . Only seven patients developed opportunistic infections. Compared to patients without infectious complications, those with infections had worse outcomes, with high rates of acute respiratory distress syndrome, intensive care unit (ICU) admission, and case-fatality rates. Neutropenia, ICU admission and high levels of C-reactive protein (CRP) were independent risk factors for infections. Conclusions Infectious complications in cancer patients with COVID-19 were lower than expected, affecting mainly neutropenic patients with high levels of CRP and/or ICU admission. The rate of opportunistic infections was unexpectedly low. The use of empiric antimicrobials in cancer patients with COVID-19 needs to be optimized.This study was supported by the Spanish Plan Nacional de IDi 2013-2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, and the Spanish Network for Research in Infectious Diseases (REIPI grant: RD16/0016/0001). It was also co-financed by the European Development Regional Fund ‘A Way to Make Europe’, Operational Programme Smart Growth 2014-2020.ElsevierInstitut Català de la Salut[Gudiol C] Department of Infectious Diseases, Biostatistics Unit, Bellvitge University Hospital, Bellvitge Institute for Biomedical Research (IDIBELL), University of Barcelona, Barcelona, Spain. Institut Català d’Oncologia, IDIBELL, University of Barcelona, Barcelona, Spain. Spainsh Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Durà-Miralles X] Department of Infectious Diseases, Biostatistics Unit, Bellvitge University Hospital, Bellvitge Institute for Biomedical Research (IDIBELL), University of Barcelona, Barcelona, Spain. Spainsh Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Aguilar-Company J] Servei d’Oncologia Mèdica; Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Hernández-Jiménez P] Infectious Diseases Unit, 12 de Octubre University Hospital, Madrid, Spain. [Martínez-Cutillas M] Medical Oncology Department, Puerta de Hierro University Hospital, Madrid, Spain. [Fernandez-Avilés F] Bone Marrow Transplantation Unit, Department of Haematology, Hospital Clinic of Barcelona, SpainVall d'Hebron Barcelona Hospital Campus202220222021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/11351/6888Scientiareponame:Scientia. Dipòsit d'Informació Digital del Departament de Salutinstname:Departament de Salut de la Generalitat de Catalunya (DS)InglésJournal of Infection;83(3)https://doi.org/10.1016/j.jinf.2021.07.014Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:scientiasalut.gencat.cat:11351/68882026-06-12T09:38:37Z |
| score |
15,81155 |